{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:10:11Z","timestamp":1790233811374,"version":"4.1.0"},"reference-count":61,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is mainly defined by hyperandrogenism but is also characterized by insulin resistance (IR). Studies showed that overexposure of nonadipose tissues to nonesterified fatty acids (NEFA) may explain both IR and hyperandrogenism. Recent studies indicate that treatment with an angiotensin II type 2 receptor (AT2R)-selective agonist improves diet-induced IR. We thus hypothesized that PCOS hyperandrogenism is triggered by ovarian NEFA overexposure and is improved after treatment with an AT2R agonist. Experiments were conducted in 12-week-old female JCR:LA-cp\/cp rats, which are characterized by visceral obesity, IR, hyperandrogenism, and polycystic ovaries. Control JCR:LA +\/? rats have a normal phenotype. Rats were treated for 8 days with saline or the selective AT2R agonist C21\/M24 and then assessed for: 1) fasting testosterone, NEFA, and insulin levels; and 2) an iv 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid test to determine NEFA ovarian tissue uptake (Km). Compared with controls, saline-treated PCOS\/cp rats displayed higher insulin (100 vs 5.6 \u03bcU\/mL), testosterone (0.12 vs 0.04 nmol\/L), NEFA (0.98 vs 0.48 mmol\/L), and Km (20.7 vs 12.9 nmol\/g\u00b7min) (all P &amp;lt; .0001). In PCOS\/cp rats, C21\/M24 did not significantly improve insulin or NEFA but normalized testosterone (P = .004) and Km (P = .009), which were strongly correlated together in all PCOS\/cp rats (\u03c1 = 0.74, P = .009). In conclusion, in an obese PCOS rat model, ovarian NEFA uptake and testosterone levels are strongly associated and are both significantly reduced after short-term C21\/M24 therapy. These findings provide new information on the role of NEFA in PCOS hyperandrogenemia and suggest a potential role for AT2R agonists in the treatment of PCOS.<\/jats:p>","DOI":"10.1210\/en.2014-1185","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T17:23:57Z","timestamp":1403889837000},"page":"3684-3693","source":"Crossref","is-referenced-by-count":20,"title":["Angiotensin II Type 2 Receptor Stimulation Improves Fatty Acid Ovarian Uptake and Hyperandrogenemia in an Obese Rat Model of Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"155","author":[{"given":"Samuel","family":"Leblanc","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Battista","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Noll","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hallberg","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry (A.H.), Biomedicinska Centrum, Uppsala University, Uppsala, Sweden 751 23;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Gallo-Payet","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"},{"name":"Centre de Recherche \u00c9tienne-Lebel (N.G.-P., A.C.C., J.-P.B.), Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Carpentier","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"},{"name":"Centre de Recherche \u00c9tienne-Lebel (N.G.-P., A.C.C., J.-P.B.), Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna F.","family":"Vine","sequence":"first","affiliation":[{"name":"Alberta Institute for Human Nutrition, Metabolic and Cardiovascular Disease Laboratory (D.F.V.), University of Alberta, Edmonton, Alberta, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Patrice","family":"Baillargeon","sequence":"first","affiliation":[{"name":"Division of Endocrinology (S.L., M.-C.B., C.N., N.G.-P., A.C.C., J.-P.B.), Department of Medicine, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"},{"name":"Centre de Recherche \u00c9tienne-Lebel (N.G.-P., A.C.C., J.-P.B.), Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"11","key":"2020071612090900500_B1","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20133","key":"2020071612090900500_B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2020071612090900500_B3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"7","key":"2020071612090900500_B4","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071612090900500_B5","first-page":"4103","article-title":"Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing","volume":"81","author":"Iba\u00f1ez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612090900500_B6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1368-504X.2004.00389.x","article-title":"Dysfunctional fat cells, lipotoxicity and type 2 diabetes","volume":"143","author":"De Fronzo","year":"2004","journal-title":"Int J Clin Pr Suppl"},{"issue":"2","key":"2020071612090900500_B7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabet.2007.10.009","article-title":"Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes","volume":"34","author":"Carpentier","year":"2008","journal-title":"Diabetes Metab"},{"issue":"4","key":"2020071612090900500_B8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2005-2069","article-title":"Free fatty acids increase androgen precursors in vivo","volume":"91","author":"Mai","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071612090900500_B9","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612090900500_B10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2011.12.017","article-title":"Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells","volume":"77","author":"Bellanger","year":"2012","journal-title":"Steroids"},{"issue":"1","key":"2020071612090900500_B11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157340212800504990","article-title":"AT2 receptor agonists: exploiting the beneficial arm of Ang II signaling Implication in adipocyte physiology and in insulin resistance","volume":"8","author":"Gallo-Payet","year":"2012","journal-title":"Curr Hypertens Rev"},{"issue":"2","key":"2020071612090900500_B12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: implications for diabetes","volume":"302","author":"Olivares-Reyes","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2020071612090900500_B13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1467-789X.2003.00091.x","article-title":"Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders","volume":"4","author":"Goossens","year":"2003","journal-title":"Obes Rev"},{"issue":"3","key":"2020071612090900500_B14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2020071612090900500_B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1470320309347791","article-title":"The past, present and future of angiotensin II type 2 receptor stimulation","volume":"11","author":"Steckelings","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"2020071612090900500_B16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1006\/bbrc.1995.1229","article-title":"Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells","volume":"207","author":"Tanaka","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2020071612090900500_B17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/002215540104900512","article-title":"Changes of AT(2) receptor levels in the rat adrenal cortex and medulla induced by bilateral nephrectomy and its modulation by circulating ANG II","volume":"49","author":"Peters","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"2020071612090900500_B18","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.hjh.0000388495.66330.63","article-title":"The angiotensin AT2 receptor in left ventricular hypertrophy","volume":"28","author":"Steckelings","year":"2010","journal-title":"J Hypertens"},{"issue":"1","key":"2020071612090900500_B19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1470320309347786","article-title":"The angiotensin II type 2 receptor and the kidney","volume":"11","author":"Siragy","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"2020071612090900500_B20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/01.HYP.0000253968.95136.b8","article-title":"Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients","volume":"49","author":"Savoia","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"2020071612090900500_B21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemari\u00e9","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"2020071612090900500_B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-012-0321-4","article-title":"Update on the angiotensin AT(2) receptor","volume":"15","author":"McCarthy","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"2020071612090900500_B23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/13543784.2012.664131","article-title":"Angiotensin II type 2 receptor agonists: where should they be applied?","volume":"21","author":"Verdonk","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"2020071612090900500_B24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrcardio.2010.85","article-title":"Novel therapeutic targets for hypertension","volume":"7","author":"Paulis","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2020071612090900500_B25","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1210\/endo-128-4-1947","article-title":"Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor","volume":"128","author":"Pucell","year":"1991","journal-title":"Endocrinology"},{"issue":"10","key":"2020071612090900500_B26","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1210\/en.2007-1767","article-title":"Regulation of angiotensin type 2 receptor in bovine granulosa cells","volume":"149","author":"Portela","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"2020071612090900500_B27","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1095\/biolreprod65.6.1672","article-title":"Localization of the renin-angiotensin system in the bovine ovary: cyclic variation of the angiotensin II receptor expression","volume":"65","author":"Schauser","year":"2001","journal-title":"Biol Reprod"},{"issue":"4","key":"2020071612090900500_B28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/endo.137.4.8625890","article-title":"Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype","volume":"137","author":"Yoshimura","year":"1996","journal-title":"Endocrinology"},{"issue":"11","key":"2020071612090900500_B29","first-page":"3914","article-title":"The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation","volume":"81","author":"Breault","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2020071612090900500_B30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/molehr\/3.8.663","article-title":"Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type-2 receptor","volume":"3","author":"Johnson","year":"1997","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"2020071612090900500_B31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/REP-11-0192","article-title":"Role of angiotensin in ovarian follicular development and ovulation in mammals: a review of recent advances","volume":"143","author":"Gon\u00e7alves","year":"2012","journal-title":"Reproduction"},{"issue":"24","key":"2020071612090900500_B32","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J Med Chem"},{"issue":"2","key":"2020071612090900500_B33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"2020071612090900500_B34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.coph.2010.11.002","article-title":"Non-peptide AT2-receptor agonists","volume":"11","author":"Steckelings","year":"2011","journal-title":"Curr Opin Pharmacol"},{"issue":"24","key":"2020071612090900500_B35","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"2020071612090900500_B36","doi-asserted-by":"crossref","first-page":"e48387","DOI":"10.1371\/journal.pone.0048387","article-title":"Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPAR\u03b3 activation","volume":"7","author":"Ohshima","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2020071612090900500_B37","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.00149.2012","article-title":"Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat\/high-fructose diet-induced insulin resistance in rats","volume":"304","author":"Shum","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"2020071612090900500_B38","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1210\/en.2008-1612","article-title":"A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome","volume":"150","author":"Shi","year":"2009","journal-title":"Endocrinology"},{"issue":"3","key":"2020071612090900500_B39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diab.46.3.513","article-title":"Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat","volume":"46","author":"Wu-Peng","year":"1997","journal-title":"Diabetes"},{"issue":"1","key":"2020071612090900500_B40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000322472","article-title":"Hypothalamic sites of leptin action linking metabolism and reproduction","volume":"93","author":"Donato","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2020071612090900500_B41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.fertnstert.2012.01.126","article-title":"The impairment of reproduction in db\/db mice is not mediated by intraovarian defective leptin signaling","volume":"97","author":"Zhang","year":"2012","journal-title":"Fertil Steril"},{"issue":"2","key":"2020071612090900500_B42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/HYPERTENSIONAHA.110.164202","article-title":"Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension","volume":"57","author":"Matavelli","year":"2011","journal-title":"Hypertension"},{"key":"2020071612090900500_B43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2014.01.044","article-title":"The angiotensin type 2 receptor agonist compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke","volume":"81","author":"Joseph","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"2020071612090900500_B44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2003-030666","article-title":"Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome","volume":"89","author":"Kasim-Karakas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071612090900500_B45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a010187","article-title":"Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies","volume":"151","author":"Hanson","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2020071612090900500_B46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archpedi.161.7.677","article-title":"Association of physical activity and body composition with insulin sensitivity in a community sample of adolescents","volume":"161","author":"Snitker","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2020071612090900500_B47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11307-006-0042-7","article-title":"The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats","volume":"8","author":"Ci","year":"2006","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"2020071612090900500_B48","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/bi9821059","article-title":"Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species","volume":"38","author":"Brock","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"2020071612090900500_B49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0021-9150(86)90004-3","article-title":"Early atherosclerotic lesions in a susceptible rat model. The LA\/N-corpulent rat","volume":"60","author":"Russell","year":"1986","journal-title":"Atherosclerosis"},{"issue":"4","key":"2020071612090900500_B50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2020071612090900500_B51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"issue":"1","key":"2020071612090900500_B52","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071612090900500_B53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2020071612090900500_B54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0889-8545(05)70189-3","article-title":"Cardiovascular risk in women with polycystic ovary syndrome","volume":"28","author":"Talbott","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"2020071612090900500_B55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/clp.11.60","article-title":"Abnormal dietary fatty acid metabolic partitioning in insulin resistance and type 2 diabetes","volume":"6","author":"Carpentier","year":"2011","journal-title":"Clin Lipidol"},{"issue":"3 pt 1","key":"2020071612090900500_B56","doi-asserted-by":"crossref","first-page":"C607","DOI":"10.1152\/ajpcell.1993.265.3.C607","article-title":"Angiotensin II type 2 receptor-modulated changes in potassium currents in cultured neurons","volume":"265","author":"Kang","year":"1993","journal-title":"Am J Physiol"},{"issue":"4","key":"2020071612090900500_B57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/frne.1997.0155","article-title":"Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review","volume":"18","author":"Lenkei","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"2020071612090900500_B58","first-page":"153","article-title":"Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure","volume":"6","author":"Danyel","year":"2013","journal-title":"Integr Blood Press Control"},{"issue":"2","key":"2020071612090900500_B59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-Degrave","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2020071612090900500_B60","doi-asserted-by":"crossref","first-page":"E1049","DOI":"10.1152\/ajpendo.00560.2009","article-title":"Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats","volume":"298","author":"M\u00e9nard","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"pt 3","key":"2020071612090900500_B61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BST0350477","article-title":"Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome","volume":"35","author":"Mangat","year":"2007","journal-title":"Biochem Soc Trans"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/155\/9\/3684\/10827768\/endo3684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/155\/9\/3684\/10827768\/endo3684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T13:53:16Z","timestamp":1746280396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/155\/9\/3684\/2423544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2014-1185","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}